{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:48:06Z","timestamp":1792759686010,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41443-021-00482-z","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T17:02:48Z","timestamp":1636218168000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-5029","authenticated-orcid":false,"given":"Joseph M.","family":"Israeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soum D.","family":"Lokeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-4181","authenticated-orcid":false,"given":"Iakov V.","family":"Efimenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1387-7904","authenticated-orcid":false,"given":"Ranjith","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.juro.2006.09.030","volume":"177","author":"R Shiri","year":"2007","unstructured":"Shiri R, Koskim\u00e4ki J, Tammela TL, H\u00e4kkinen J, Auvinen A, Hakama M. Bidirectional relationship between depression and erectile dysfunction. J Urol. 2007;177:669\u201373.","journal-title":"J Urol"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/JU.0000000000001426","volume":"205","author":"R Kuja-Halkola","year":"2021","unstructured":"Kuja-Halkola R, Henningsohn L, D\u2019Onofrio BM, Mills J, Adolfsson A, Larsson H, et al. Mental disorders in Peyronie\u2019s disease: a Swedish cohort study of 3.5 Million Men. J Urol. 2021;205:864\u201370. https:\/\/doi.org\/10.1097\/JU.0000000000001426","journal-title":"J Urol"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kjms.2015.10.008","volume":"32","author":"L Hou","year":"2016","unstructured":"Hou L, Dong Q, Wu Y-J, Sun Y-X, Guo Y-Y, Huo Y-H. Gonadotropins facilitate potential differentiation of human bone marrow mesenchymal stem cells into Leydig cells in vitro. Kaohsiung J Med Sci. 2016;32:1\u20139.","journal-title":"Kaohsiung J Med Sci"},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.euf.2017.06.009","volume":"3","author":"R Yiou","year":"2017","unstructured":"Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, et al. Intracavernous injections of bone marrow mononucleated cells for postradical prostatectomy erectile dysfunction: final results of the INSTIN clinical trial. Eur Urol Focus. 2017;3:643\u20135.","journal-title":"Eur Urol Focus"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","volume":"59","author":"EL Matz","year":"2018","unstructured":"Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59:61\u201365. https:\/\/doi.org\/10.4111\/icu.2018.59.1.61.","journal-title":"Investig Clin Urol"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2016.06.007","volume":"19","author":"L Turner","year":"2016","unstructured":"Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19:154\u20137.","journal-title":"Cell Stem Cell"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","volume":"270","author":"NIH Consensus Conference. Impotence.","year":"1993","unstructured":"NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83\u201390. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8510302 Retrieved from","journal-title":"JAMA"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","volume":"151","author":"HA Feldman","year":"1994","unstructured":"Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54\u201361.","journal-title":"J Urol"},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/S0022-5347(17)43655-X","volume":"138","author":"PN Schlegel","year":"1987","unstructured":"Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987;138:1402\u20136.","journal-title":"J Urol"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","volume":"84","author":"I Ayta","year":"1999","unstructured":"Ayta I, McKinlay J, Krane R. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50\u201356.","journal-title":"BJU Int"},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1464-410X.2010.09944.x","volume":"108","author":"M Abidu\u2010Figueiredo","year":"2011","unstructured":"Abidu\u2010Figueiredo M, Ribeiro IC, Chagas MA, Cardoso LE, Costa WS, Sampaio FJ. The penis in diabetes: structural analysis of connective tissue and smooth muscle alterations in a rabbit model. BJU Int. 2011;108:400\u20134.","journal-title":"BJU Int"},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1432-0436.2006.00081.x","volume":"74","author":"H Ning","year":"2006","unstructured":"Ning H, Lin G, Lue TF, Lin C-S. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation. 2006;74:510\u20138.","journal-title":"Differentiation"},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F Togel","year":"2005","unstructured":"Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol-Ren Physiol. 2005;289:F31\u2013F42.","journal-title":"Am J Physiol-Ren Physiol"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.urology.2018.06.018","volume":"121","author":"MK Haahr","year":"2018","unstructured":"Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, S\u00f8rensen JA, et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology. 2018;121:e6\u2013203. e13. 203","journal-title":"Urology"},{"key":"482_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.7556\/jaoa.2016.007","volume":"116","author":"JA Levy","year":"2016","unstructured":"Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells. J Osteopath Med. 2016;116:e1\u2013e5.","journal-title":"J Osteopath Med"},{"key":"482_CR16","first-page":"150","volume":"8","author":"JY Bahk","year":"2010","unstructured":"Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transpl. 2010;8:150\u201360.","journal-title":"Exp Clin Transpl"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000492120","volume":"101","author":"S Al Demour","year":"2018","unstructured":"Al Demour S, Jafar H, Adwan S, AlSharif A, Alhawari H, Alrabadi A, et al. Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: an open-label phase I clinical trial. Urol Int. 2018;101:358\u201365.","journal-title":"Urol Int"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2015.09.026","volume":"69","author":"R Yiou","year":"2016","unstructured":"Yiou R, Hamidou L, Birebent B, Bitari D, Lecorvoisier P, Contremoulins I, et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: an open dose-escalation pilot study. Eur Urol. 2016;69:988\u201391.","journal-title":"Eur Urol"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2016.01.024","volume":"5","author":"MK Haahr","year":"2016","unstructured":"Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, Sorensen JA, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine. 2016;5:204\u201310. https:\/\/doi.org\/10.1016\/j.ebiom.2016.01.024","journal-title":"EBioMedicine"},{"key":"482_CR20","doi-asserted-by":"publisher","unstructured":"Protogerou V, Michalopoulos E, Mallis P, Gontika I, Dimou Z, Liakouras C, et al. Administration of adipose-derived mesenchymal stem cells and platelet lysate in erectile dysfunction: a single-center pilot study. Bioengineering. 2019;6. https:\/\/doi.org\/10.3390\/bioengineering6010021","DOI":"10.3390\/bioengineering6010021"},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jsxm.2020.01.003","volume":"17","author":"J Ory","year":"2020","unstructured":"Ory J, Saltzman RG, Blachman-Braun R, Dadoun S, DiFede DL, Premer C, et al. The effect of transendocardial stem cell injection on erectile function in men with cardiomyopathy: results from the TRIDENT, POSEIDON, and TAC-HFT trials. J Sex Med. 2020;17:695\u2013701. https:\/\/doi.org\/10.1016\/j.jsxm.2020.01.003","journal-title":"J Sex Med"},{"key":"482_CR22","doi-asserted-by":"crossref","unstructured":"Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, et al. Platelet-rich plasma: The choice of activation method affects the release of bioactive molecules. BioMed Research International [Internet]. 2016;2016:1\u20137. Available from: https:\/\/www.hindawi.com\/journals\/bmri\/2016\/6591717\/.","DOI":"10.1155\/2016\/6591717"},{"key":"482_CR23","doi-asserted-by":"crossref","unstructured":"Epifanova MV, Chalyi ME, Krasnov AO. Investigation of mechanisms of action of growth factors of autologous platelet-rich plasma used to treat erectile dysfunction. Urologiia. 2017;46\u20138. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28952692","DOI":"10.18565\/urology.2017.4.46-48"},{"key":"482_CR24","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/ijms18081794","volume":"18","author":"JD Campbell","year":"2017","unstructured":"Campbell JD, Burnett AL. Neuroprotective and nerve regenerative approaches for treatment of erectile dysfunction after cavernous nerve injury. Int J Mol Sci. 2017;18:1794.","journal-title":"Int J Mol Sci"},{"key":"482_CR25","unstructured":"Chalyj ME, Grigorjan VA, Epifanova MV, Krasnov AO. The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction. Urologiia. 2015:76\u20139. Russian. PMID: 26665770."},{"key":"482_CR26","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jsxm.2019.03.228","volume":"16","author":"S Alkhayal","year":"2019","unstructured":"Alkhayal S, Lourdes M. PO-01-091 Platelet-rich plasma penile rejuvenation as a treatment for erectile dysfunction: an update. J Sex Med. 2019;16:S71.","journal-title":"J Sex Med"},{"key":"482_CR27","doi-asserted-by":"publisher","first-page":"100313","DOI":"10.1016\/j.esxm.2020.100313","volume":"9","author":"T Ta\u015f","year":"2021","unstructured":"Ta\u015f T, \u00c7ak\u0131ro\u011flu B, Arda E, Onuk \u00d6, Nuho\u011flu B. Early clinical results of the tolerability, safety, and efficacy of autologous platelet-rich plasma administration in erectile dysfunction. Sex Med. 2021;9:100313.","journal-title":"Sex Med"},{"key":"482_CR28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jsxm.2021.03.008","volume":"18","author":"E Poulios","year":"2021","unstructured":"Poulios E, Mykoniatis I, Pyrgidis N, Zilotis F, Kapoteli P, Kotsiris D, et al. Platelet-rich plasma (PRP) improves erectile function: a double-blind, randomized, placebo-controlled clinical trial. J Sex Med. 2021;18:926\u201335.","journal-title":"J Sex Med"},{"key":"482_CR29","unstructured":"Ramasamy R. Safety and efficacy of autologous platelet-rich plasma for erectile dysfunction. In. University of Miami Miller School of Medicine 2021."},{"key":"482_CR30","first-page":"425","volume":"1","author":"F de la Peyronie","year":"1743","unstructured":"de la Peyronie F. Sur quelques obstacles qui s\u2019 opposent a l\u2019ejaculation naturelle de la semence. Mem Acad R Chir. 1743;1:425\u201334.","journal-title":"Mem Acad R Chir"},{"key":"482_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","volume":"51","author":"SM Haag","year":"2007","unstructured":"Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha E-S, Weidner W, et al. Alterations in the transforming growth factor (TGF)-\u03b2 pathway as a potential factor in the pathogenesis of Peyronie\u2019s disease. Eur Urol. 2007;51:255\u201361.","journal-title":"Eur Urol"},{"key":"482_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0022-5347(17)37988-0","volume":"146","author":"MB Lindsay","year":"1991","unstructured":"Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie\u2019s disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991;146:1007\u20139.","journal-title":"J Urol"},{"key":"482_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.ijir.3900622","volume":"12","author":"M Braun","year":"2000","unstructured":"Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the \u2018Cologne Male Survey\u2019. Int J Impot Res. 2000;12:305\u201311.","journal-title":"Int J Impot Res"},{"key":"482_CR34","doi-asserted-by":"publisher","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","volume":"11","author":"M Stuntz","year":"2016","unstructured":"Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie\u2019s disease in the United States: a population-based study. PLoS ONE. 2016;11:e0150157.","journal-title":"PLoS ONE"},{"key":"482_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2020.07.013","volume":"104","author":"BS Hatfield","year":"2020","unstructured":"Hatfield BS, King CR, Udager AM, Williamson SR, Gandhi JS, Amin MB, et al. Peyronie disease: a clinicopathologic study of 71 cases with emphasis on histopathologic patterns and prevalent metaplastic ossification. Hum Pathol. 2020;104:9\u201317.","journal-title":"Hum Pathol"},{"key":"482_CR36","doi-asserted-by":"publisher","unstructured":"de Jes\u00fas MR, Ramasamy R, Ibrahim E, Molina M, Masterson TA 3rd. The use of ultrasonography in the evaluation and management of peyronie\u2019s disease. Urol Video J. 2020;7:100047. https:\/\/doi.org\/10.1016\/j.urolvj.2020.100047. Epub 2020 Jun 15. PMID: 32724898; PMCID: PMC7386432.","DOI":"10.1016\/j.urolvj.2020.100047"},{"key":"482_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1743-6109.2011.02510.x","volume":"9","author":"E Chung","year":"2012","unstructured":"Chung E, De Young L, Brock G. Penile traction and Peyronie\u2019s disease: in-vitro analysis of the efficacy of traction on cellular changes in Peyronie\u2019s plaque in a strain culture system. J Sex Med. 2012;9:130\u2013130.","journal-title":"J Sex Med"},{"key":"482_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","volume":"44","author":"E Akkus","year":"1994","unstructured":"Akkus E, Breza J, Carrier S, Kadioglu A, Rehman J, Lue TE. Is colchicine effective in Peyronie\u2019sdisease? A pilot study. Urology. 1994;44:291\u20135.","journal-title":"Urology"},{"key":"482_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","volume":"47","author":"W Weidner","year":"2005","unstructured":"Weidner W, Hauck EW, Schnitker J, Group, P. s. D. S. Potassium paraaminobenzoate (POTABA\u2122) in the treatment of Peyronie\u2019s disease: a prospective, placebo-controlled, randomized study. Eur Urol. 2005;47:530\u20136.","journal-title":"Eur Urol"},{"key":"482_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/aja.2010.117","volume":"13","author":"JF Smith","year":"2011","unstructured":"Smith JF, Shindel AW, Huang YC, Clavijo RI, Flechner L, Breyer BN, et al. Pentoxifylline treatment and penile calcifications in men with Peyronie\u2019s disease. Asian J Androl. 2011;13:322\u20135. https:\/\/doi.org\/10.1038\/aja.2010.117","journal-title":"Asian J Androl"},{"key":"482_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","volume":"9","author":"EG Valente","year":"2003","unstructured":"Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie\u2019s fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9:229\u201344.","journal-title":"Nitric Oxide"},{"key":"482_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","volume":"168","author":"LA Levine","year":"2002","unstructured":"Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie\u2019s disease. J Urol. 2002;168:621\u20136.","journal-title":"J Urol"},{"key":"482_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000480857","volume":"32","author":"HE Wegner","year":"1997","unstructured":"Wegner HE, Andresen R, Knispel HH, Miller K. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie\u2019s disease. Eur Urol. 1997;32:190\u20133. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9286652 Retrieved from","journal-title":"Eur Urol"},{"key":"482_CR44","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jsxm.2017.08.015","volume":"14","author":"DJ Ralph","year":"2017","unstructured":"Ralph DJ, Raheem AA, Liu G. Treatment of Peyronie\u2019s disease with Collagenase Clostridium histolyticum and vacuum therapy: a randomized, open-label pilot study. J Sex Med. 2017;14:1430\u20137.","journal-title":"J Sex Med"},{"key":"482_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.urology.2007.11.065","volume":"71","author":"DH Kim","year":"2008","unstructured":"Kim DH, Lesser TF, Aboseif SR. Subjective patient-reported experiences after surgery for Peyronie\u2019s disease: corporeal plication versus plaque incision with vein graft. Urology. 2008;71:698\u2013702.","journal-title":"Urology"},{"key":"482_CR46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","volume":"152","author":"SK Wilson","year":"1994","unstructured":"Wilson SK, Delk JR II. A new treatment for Peyronie\u2019s disease: modeling the penis over an inflatable penile prosthesis. J Urol. 1994;152:1121\u20133.","journal-title":"J Urol"},{"key":"482_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00345-012-0859-4","volume":"31","author":"E Chung","year":"2013","unstructured":"Chung E, Van C, Wilson I, Cartmill R. Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol. 2013;31:591\u20135.","journal-title":"World J Urol"},{"key":"482_CR48","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1097\/GOX.0000000000000622","volume":"4","author":"EB Lander","year":"2016","unstructured":"Lander EB, Berman MH, See JR. Stromal vascular fraction combined with shock wave for the treatment of Peyronie\u2019s disease. Plast Reconstr Surg Glob Open. 2016;4:e631 https:\/\/doi.org\/10.1097\/GOX.0000000000000622","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"482_CR49","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1016\/j.jsxm.2020.04.183","volume":"17","author":"M Epifanova","year":"2020","unstructured":"Epifanova M, Kaprin A, Kostin A, Gvasalia B, Chalyy M, Artemenko S, et al. P-02-29 platelet-rich plasma and shockwave therapy combination for Peyronie\u2019s disease treatment. J Sex Med. 2020;17:S180.","journal-title":"J Sex Med"},{"key":"482_CR50","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1111\/jsm.12275","volume":"10","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S. Extracorporeal shock wave therapy in Peyronie\u2019s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med. 2013;10:2815\u201321.","journal-title":"J Sex Med"},{"key":"482_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","volume":"157","author":"KD Somers","year":"1997","unstructured":"Somers KD, Dawson DM. Fibrin deposition in Peyronie\u2019s disease plaque. J Urol. 1997;157:311\u20135.","journal-title":"J Urol"},{"key":"482_CR52","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1038\/jid.2014.169","volume":"134","author":"S Liu","year":"2014","unstructured":"Liu S, Jiang L, Li H, Shi H, Luo H, Zhang Y, et al. Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J Investig Dermatol. 2014;134:2648\u201357.","journal-title":"J Investig Dermatol"},{"key":"482_CR53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","volume":"63","author":"F Castiglione","year":"2013","unstructured":"Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie\u2019s disease. Eur Urol. 2013;63:551\u201360.","journal-title":"Eur Urol"},{"key":"482_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.2047-2927.2013.00181.x","volume":"2","author":"A Gokce","year":"2014","unstructured":"Gokce A, Abd Elmageed ZY, Lasker GF, Bouljihad M, Kim H, Trost L, et al. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie\u2019s disease. Andrology. 2014;2:244\u201351.","journal-title":"Andrology"},{"key":"482_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5534\/wjmh.180100","volume":"37","author":"M Di Mauro","year":"2019","unstructured":"Di Mauro M, Russo GI, Della Camera PA, Di Maida F, Cito G, Mondaini N, et al. Extracorporeal shock wave therapy in Peyronie\u2019s disease: clinical efficacy and safety from a single-arm observational study. World J Men\u2019s Health. 2019;37:339\u201346.","journal-title":"World J Men\u2019s Health"},{"key":"482_CR56","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.7556\/jaoa.2015.124","volume":"115","author":"JA Levy","year":"2015","unstructured":"Levy JA, Marchand M, Iorio L, Zribi G, Zahalsky MP. Effects of stem cell treatment in human patients with Peyronie disease. J Osteopath Med. 2015;115:e8\u2013e13.","journal-title":"J Osteopath Med"},{"key":"482_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/14653240902824773","volume":"11","author":"K Okabe","year":"2009","unstructured":"Okabe K, Yamada Y, Ito K, Kohgo T, Yoshimi R, Ueda M. Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds. Cytotherapy. 2009;11:307\u201316.","journal-title":"Cytotherapy"},{"key":"482_CR58","first-page":"1","volume":"2017","author":"R Virag","year":"2017","unstructured":"Virag R, Sussman H, Lambion S, de Fourmestraux V. Evaluation of the benefit of using a combination of autologous platelet rich-plasma and hyaluronic acid for the treatment of Peyronie\u2019s disease. Sex Health. 2017;2017:1.","journal-title":"Sex Health"},{"key":"482_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0748806818798280","volume":"36","author":"I Marcovici","year":"2019","unstructured":"Marcovici I. PRP and correction of penile curvature (Peyronie\u2019s disease). Am J Cosmet Surg. 2019;36:117\u201320.","journal-title":"Am J Cosmet Surg"},{"key":"482_CR60","doi-asserted-by":"publisher","unstructured":"Alkandari MH, Touma N, Carrier S. Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie\u2019s Disease: A Systematic Review of Evidence. Sex Med Rev. 2021:S2050-0521(21)00003-2. https:\/\/doi.org\/10.1016\/j.sxmr.2020.12.004. Epub ahead of print. PMID: 34219010.","DOI":"10.1016\/j.sxmr.2020.12.004"},{"key":"482_CR61","unstructured":"Ramasamy R. PRP for treatment of Peyronie\u2019s disease. In. University of Miami Miller, School of Medicine. 2021."},{"key":"482_CR62","unstructured":"Code of Federal Regulations Title 21, \u00a7 1271.15. 2020."},{"key":"482_CR63","unstructured":"Storrs C. Is platelet-rich plasma an effective healing therapy. Sci Am 2009."},{"key":"482_CR64","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","volume":"200","author":"AL Burnett","year":"2018","unstructured":"Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633\u201341.","journal-title":"J Urol"},{"key":"482_CR65","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194:745\u201353.","journal-title":"J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00482-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T20:03:10Z","timestamp":1652904190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1038\/s41443-021-00482-z","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"16 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thomas Masterson: Isr Endo Pharm Ranjith Ramasamy: Acerus Pharmaceuticals: Consultant Grant Recipient, Boston Scientific: Consultant, Grant Recipient, Coloplast: Grant recipient, Endo Pharmaceuticals: Consultant, grant recipient, Empower Pharmacy: grant recipient, nestle health: consultant, Olympus: grant recipient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval was required for this review paper that solely analyzed research papers and did not conduct any direct research with human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}